Focus on Cardiovascular Outcomes Among Women1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Petronio has served as a consultant for Boston Scientific, Medtronic, and Abbott Vascular. Dr. Mehilli has received lecture fees from Edwards Lifesciences, Abbott Vascular, Biotronik, Lilly/Daiichi-Sankyo, Terumo, and Bristol-Myers Squibb; and institutional research grant support from Abbott Vascular and Edwards Lifesciences. Dr. Lefèvre has served as a proctor for Edwards Lifesciences. Dr. Sardella has received proctor fees for Edwards Lifesciences; and speaker fees from Direct Flow. Dr. Van Mieghem has received research grant support from Boston Scientific, Edwards Lifesciences, Medtronic, St. Jude Medical, Abbott Vascular, and Claret Medical. Dr. Dumonteil has received proctor fees from Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott Vascular. Dr. Mikhail is the director of the Imperial Valve and Cardiovascular Course. Dr. S. Sharma has served on the Speakers Bureau for Boston Scientific, Abbott Vascular, Cardiovascular Systems Inc., and TriReme. Dr. Naber has received speaker fees from Edwards Lifesciences, Direct Flow Medical, Medtronic, and Claret; is a minor shareholder with Claret; and has served as an advisor for Direct Flow Medical. Dr. Mehran has received institutional research grant support from Eli Lilly/Daiichi-Sankyo Inc., AstraZeneca, The Medicines Company, Bristol-Myers Squibb, OrbusNeich, Beth Israel Deaconess, and Bayer; has served as a consultant for Boston Scientific, Cardiovascular Systems Inc., Medscape, and Shanghai BraccoSine Pharmaceutical; has received institutional advisory board funding from Bristol-Myers Squibb; has received institutional funding from Claret Medical; owns equity in Claret Medical and Elixir Medical; has served on the executive committee for Janssen Pharmaceuticals and Osprey Medical; has served on the data safety monitoring board for Watermark Research Partners; and has a spouse who has served as a consultant for Abiomed and the Medicines Company. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.